Praxis Precision Medicines Target Price

Analysts' average 12-month price target for Praxis Precision Medicines is $580.

Get informed when a big investor buys or sells

+ Follow

Share Price

$355.15

Average Target Price

$583.58

64.3% upside

19 analysts in the last 4 months

High: $1245 | Low: $162

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-21	Goldman Sachs	$575	61.9% upside
2026-08-17	Raymond JamesTiago Fauth	$945	166.1% upside
2026-08-07	RBC CapitalLeonid Timashev	$462	30.1% upside
2026-08-07	Robert W. Baird	$514	44.7% upside
2026-08-07	Wells FargoBenjamin Burnett	$362	1.9% upside
2026-07-13	Goldman Sachs	$447	25.9% upside
2026-06-29	NeedhamAmi Fadia	$575	61.9% upside
2026-06-17	RBC CapitalLeonid Timashev	$449	26.4% upside
2026-06-02	Truist Financial	$616	73.4% upside
2026-06-02	Wedbush	$162	54.4% downside
2026-06-02	OppenheimerJay Olson	$650	83% upside
2026-06-02	Robert W. Baird	$400	12.6% upside
2026-06-02	H.C. Wainwright	$1,201	238.2% upside
2026-06-02	BTIGKambiz Yazdi	$810	128.1% upside
2026-06-02	Deutsche BankDavid Hoang	$374	5.3% upside
2026-05-26	H.C. WainwrightDouglas Tsao	$1,245	250.6% upside
2026-05-13	Truist Financial	$715	101.3% upside
2026-05-08	Wedbush	$166	53.3% downside
2026-05-08	Deutsche Bank	$420	18.3% upside
2026-04-15	Deutsche Bank	$437	23% upside
2026-04-10	Raymond James	$815	129.5% upside
2026-02-23	Wolfe Research	$500	40.8% upside
2026-02-20	Truist Financial	$700	97.1% upside
2026-02-20	Deutsche Bank	$412	16% upside
2026-02-20	Robert W. Baird	$433	21.9% upside
2026-02-20	Wells Fargo	$305	14.1% downside
2026-02-10	Guggenheim	$800	125.3% upside
2026-02-04	Needham	$510	43.6% upside
2026-02-02	Wells Fargo	$282	20.6% downside
2026-01-05	NeedhamAmi Fadia	$460	29.5% upside
2025-12-29	BTIG	$843	137.4% upside
2025-12-15	UBS	$750	111.2% upside
2025-12-15	OppenheimerJay Olson	$750	111.2% upside
2025-12-12	Deutsche Bank	$313	11.9% downside
2025-12-09	Jefferies	$450	26.7% upside
2025-12-09	GuggenheimYatin Suneja	$760	114% upside
2025-12-08	Truist Financial	$500	40.8% upside
2025-12-08	Needham	$315	11.3% downside
2025-12-08	BTIGKambiz Yazdi	$507	42.8% upside
2025-12-05	Deutsche Bank	$303	14.7% downside
2025-12-05	Wedbush	$83	76.6% downside
2025-12-05	Piper SandlerYasmeen Rahimi	$450	26.7% upside
2025-12-05	BTIG	$499	40.5% upside
2025-12-05	NeedhamAmi Fadia	$304	14.4% downside
2025-12-05	H.C. Wainwright	$340	4.3% downside
2025-11-18	BTIG	$424	19.4% upside
2025-11-06	GuggenheimYatin Suneja	$540	52% upside
2025-10-17	Deutsche Bank	$280	21.2% downside
2025-10-17	Chardan Capital	$330	7.1% downside
2025-10-16	JefferiesAndrew Tsai	$300	15.5% downside

Praxis Precision Medicines (PRAX) FAQ

Praxis Precision Medicines (PRAX) currently reports a target price of $580. Use the charts on this page to explore Praxis Precision Medicines's target price history and peer comparisons.

Analysts' average 12-month price target for Praxis Precision Medicines is $580, about 64.3% upside from the current share price of $355.15. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $580, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Praxis Precision Medicines, and consider following PRAX for alerts when major investors trade the stock.

Praxis Precision Medicines is classified in the Healthcare sector. On target price, it currently shows $580. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRAX with unrelated industries.